SV LIFE SCIENCES FUND IV, L.P.

CIK 00013673816 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001367381

Recent Transactions

50 trades

Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-04-10$29.40/sh−13,157→ 1,672,105 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-04-10$29.40/sh−374→ 47,471 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-04-09$28.53/sh−377→ 47,845 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-04-09$28.53/sh−13,292→ 1,685,262 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-04-08$29.49/sh−629→ 48,222 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-04-08$29.49/sh−22,171→ 1,698,554 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-04-02$28.76/sh−253→ 48,851 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-04-02$28.76/sh−8,888→ 1,720,725 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-04-01$27.66/sh−51,373→ 1,729,613 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-04-01$27.66/sh−1,458→ 49,104 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-03-29$28.40/sh−969→ 50,562 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-03-29$28.40/sh−34,133→ 1,780,986 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-03-28$27.80/sh−1,012→ 51,531 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-03-28$27.80/sh−35,653→ 1,815,119 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-03-27$29.06/sh−56,318→ 1,850,772 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-03-27$29.06/sh−1,599→ 52,543 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-03-26$29.70/sh−29,262→ 1,907,090 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-03-26$29.70/sh−831→ 54,142 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-03-18$26.70/sh−7,246→ 54,973 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-03-18$26.70/sh−255,224→ 1,936,352 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-03-05$23.04/sh−893→ 62,219 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-03-05$23.04/sh−31,439→ 2,191,576 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-03-04$22.91/sh−1,197→ 63,112 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-03-04$22.91/sh−42,181→ 2,223,015 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-02-21$20.60/sh−4,764→ 64,309 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-02-21$20.60/sh−167,779→ 2,265,196 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-02-20$20.02/sh−641→ 69,073 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-02-20$20.02/sh−22,594→ 2,432,975 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-02-19$20.73/sh−508→ 69,714 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-02-19$20.73/sh−17,912→ 2,455,569 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-01-07$20.41/sh−72→ 70,222 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-01-07$20.41/sh−2,527→ 2,473,481 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-01-03$20.01/sh−1,653→ 2,476,008 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-01-03$20.01/sh−47→ 70,294 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-01-02$20.00/sh−6→ 70,341 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2019-01-02$20.00/sh−194→ 2,477,661 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2018-12-31$20.00/sh−24,716→ 2,477,855 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2018-12-31$20.00/sh−702→ 70,347 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2018-12-28$20.03/sh−3,631→ 2,502,571 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2018-12-28$20.03/sh−103→ 71,049 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2018-12-19$20.02/sh−59→ 71,152 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2018-12-19$20.02/sh−2,077→ 2,506,202 total
Sale
ENTELLUS MEDICAL INC
Common Stock, $0.001 par value
2017-01-31$17.00/sh−299,424→ 1,791,070 total
Sale
ENTELLUS MEDICAL INC
Common Stock, $0.001 par value
2017-01-31$17.00/sh−2,106→ 10,424 total
Sale
ENTELLUS MEDICAL INC
Common Stock, $0.001 par value
2017-01-31$17.00/sh−8,501→ 50,849 total
Sale
ENTELLUS MEDICAL INC
Common Stock, $0.001 par value
2017-01-31$17.00/sh−220,431→ 1,091,166 total
Sale
ENTELLUS MEDICAL INC
Common Stock, $0.001 par value
2017-01-31$17.00/sh−2,615→ 12,947 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2016-11-21+2,508,279→ 2,508,279 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2016-11-21+71,211→ 71,211 total
Sale
OCULAR THERAPEUTIX, INC$OCUL
Common Stock
2015-06-10$22.00/sh−362,703→ 2,151,523 total

Companies

Recent Filings

Address

60 STATE STREET SUITE 3650

BOSTON, MA, 02109

View on SEC.gov